Cambridge Healthtech Institute’s Inaugural

Biophysical Analysis and Developability

New Technologies and Strategies for Predicting and Characterising Biophysical Attributes

11-12 March 2026

 

As therapeutic formats grow more complex, biophysical characterisation and developability assessments must evolve in parallel. Biophysical Analysis and Developability will present next-generation methods and models for predicting aggregation, stability, and manufacturability—alongside automation and miniaturisation strategies that improve throughput and data quality. Presenters will highlight emerging tools such as microfluidics, single-cell platforms, and MS-based analytics, as well as computational frameworks that support early-stage screening and platform decision-making. Sessions will also cover applications of MAM, advances in low-volume assay sensitivity, and performance enhancements for core legacy methods. This track offers a focused look at how biophysical sciences are enabling better candidate selection and reducing risk in the earliest stages of development.

 

Coverage will include, but is not limited to:

 

  • Automation and miniaturisation
  • Biophysical characterisation for new modalities
  • Computational modelling of biophysical properties and developability prediction models
  • Developability assays, data generation, and models
  • Emerging tools for low volume, high sensitivity, and microfluidic biophysical assays
  • Incremental improvements in capacity, efficiency, and robustness for legacy biophysical methods
  • Methods and models for prediction of aggregation and stability
  • MS applications and technologies
  • New MAM applications in early development and QC
  • New technologies
  • Stability prediction for novel biotherapeutic formats

 

The deadline for priority consideration is Friday 12 September

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

Opportunities for Participation:

 


For more details on the conference, please contact:

Kent Simmons

Senior Conference Director

Cambridge Healthtech Institute

Phone: +1-207-329-2964

Email: ksimmons@healthtech.com

 

For sponsorship information, please contact:

 

Companies A-K

Phillip Zakim-Yacouby

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (1+) 781-247-1815

Email: pzakim-yacouby@cambridgeinnovationinstitute.com

 

Companies L-Z

Aimee Croke

Business Development Manager

Cambridge Healthtech Institute

Phone: (1+) 781-292-0777

Email: acroke@cambridgeinnovationinstitute.com